SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 2435.20 millions, down -33.17% for the March 2024 quarter as against Rs. 3643.90 millions during the year-ago period.A big decline of -58.95% was reported for the quarter ended March 2024 to Rs. 534.31  millions from Rs. 1301.61 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 890.07 millions from 1881.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2435.20 3643.90 -33.17 10249.93 13300.80 -22.94 10249.93 13300.80 -22.94
Other Income 168.66 107.55 56.82 550.93 445.52 23.66 550.93 445.52 23.66
PBIDT 890.07 1881.58 -52.70 4649.93 6352.40 -26.80 4649.93 6352.40 -26.80
Interest 22.88 50.02 -54.26 74.27 127.48 -41.74 74.27 127.48 -41.74
PBDT 867.19 1831.56 -52.65 4575.66 6224.92 -26.49 4575.66 6224.92 -26.49
Depreciation 156.65 106.91 46.53 487.92 430.99 13.21 487.92 430.99 13.21
PBT 710.54 1724.65 -58.80 4087.74 5793.93 -29.45 4087.74 5793.93 -29.45
TAX 176.23 423.04 -58.34 1039.59 1467.91 -29.18 1039.59 1467.91 -29.18
Deferred Tax -10.66 15.09 -170.64 65.92 43.38 51.96 65.92 43.38 51.96
PAT 534.31 1301.61 -58.95 3048.15 4326.02 -29.54 3048.15 4326.02 -29.54
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 36.55 51.64 -29.22 45.37 47.76 -5.01 45.37 47.76 -5.01

Cohance Lifesciences Share Price

365.50 3.60 (0.99%)
22-Apr-2026 11:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.60
Dr. Reddys Lab 1219.95
Cipla 1229.30
Zydus Lifesciences 930.70
Lupin 2309.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×